Specialty Testing for Gastrointestinal Health: Stool, Microbiome, and Digestive Markers

Digestive symptoms are common, but their causes can be surprisingly difficult to identify.

Bloating, diarrhea, constipation, abdominal discomfort, changes in stool consistency, food-related symptoms, and unexplained digestive problems may arise from many different conditions. Sometimes routine laboratory testing and a careful medical history provide the answer. In other situations, more focused gastrointestinal testing may be considered.

Specialty gastrointestinal testing often uses stool samples to evaluate markers related to intestinal inflammation, digestive function, microorganisms, infection, and other aspects of gastrointestinal health.

However, these tests vary substantially in their clinical usefulness.

Some stool markers—such as fecal calprotectin and fecal pancreatic elastase—have established clinical applications. Other measurements commonly included on comprehensive microbiome or functional stool panels have much less evidence supporting their use for diagnosis or treatment decisions.

For that reason, the value of gastrointestinal testing depends less on the number of biomarkers included and more on whether the test answers a meaningful clinical question.

Patients interested in advanced laboratory evaluation can learn more through our Specialty Laboratory Testing service or begin with our complete guide to specialty laboratory testing.

What Is Specialty Gastrointestinal Testing?

Specialty gastrointestinal testing refers to laboratory testing designed to investigate selected aspects of digestive health beyond—or in greater detail than—routine blood work.

Depending on the clinical question, testing may involve:

• Stool

• Blood

• Breath

• Urine

• Tissue obtained during endoscopy

• Other specialized specimens

Stool testing is particularly useful because stool may contain measurable evidence of intestinal inflammation, pancreatic digestive function, infection, blood loss, and microorganisms living within the gastrointestinal tract.

Some comprehensive gastrointestinal panels combine numerous measurements into a single report.

These may include:

• Bacteria

• Parasites

• Viruses

• Yeast or fungi

• Inflammatory markers

• Pancreatic digestive markers

• Markers related to digestion or absorption

• Microbiome composition

• Selected immune markers

• Microbial metabolites

• Other gastrointestinal biomarkers

A large panel is not automatically a better test.

The important question is whether a particular measurement is sufficiently reliable, clinically interpretable, and relevant to the patient's symptoms to influence medical decision-making.

What Can Stool Testing Tell a Physician?

The answer depends heavily on the specific test being ordered.

Some stool tests look for a very specific disease process. Others provide a broader description of the organisms or biomarkers detected within a sample.

These categories should not be treated as equivalent.

Gastrointestinal Pathogens

Stool testing can help identify certain organisms capable of causing gastrointestinal infection.

Depending on the laboratory and clinical situation, testing may evaluate organisms such as:

• Bacteria

• Parasites

• Viruses

• Selected bacterial toxins

Modern gastrointestinal pathogen panels may use polymerase chain reaction, or PCR, to detect genetic material associated with multiple organisms simultaneously.

This can be valuable in appropriately selected patients with diarrhea or suspected gastrointestinal infection.

However, detecting genetic material from an organism does not always mean that organism is responsible for a patient's symptoms.

Clinical interpretation remains important because some microorganisms may represent colonization, recent exposure, or findings that do not require treatment.

The American Gastroenterological Association, for example, recommends targeted stool testing for Giardia in appropriate patients being evaluated for chronic watery diarrhea and also supports selected inflammatory stool markers as part of that evaluation.

Fecal Calprotectin and Intestinal Inflammation

Fecal calprotectin is one of the most clinically established gastrointestinal stool markers.

Calprotectin is released by inflammatory cells and can increase when significant inflammation is occurring within the gastrointestinal tract.

Physicians may use fecal calprotectin to help distinguish inflammatory gastrointestinal disease from certain non-inflammatory conditions.

For example, it can be useful when evaluating whether symptoms suggest inflammatory bowel disease rather than a functional disorder such as irritable bowel syndrome.

The American College of Gastroenterology and American Gastroenterological Association recognize fecal calprotectin as a useful noninvasive inflammatory marker in selected gastrointestinal evaluations.

Importantly, an elevated calprotectin result does not independently diagnose Crohn's disease or ulcerative colitis.

Other conditions can increase intestinal inflammation, and abnormal results may require additional evaluation such as blood testing, imaging, gastroenterology consultation, colonoscopy, or other diagnostic procedures.

Likewise, the interpretation of a mildly elevated value may differ substantially from that of a markedly elevated value.

The result needs context.

Fecal Lactoferrin

Fecal lactoferrin is another stool marker associated with intestinal inflammation.

Like fecal calprotectin, it may help physicians determine whether gastrointestinal symptoms are more likely to involve an inflammatory process.

It does not identify the specific cause of the inflammation.

A physician must still determine whether the clinical picture suggests:

• Inflammatory bowel disease

• Gastrointestinal infection

• Another inflammatory condition

• A different explanation entirely

Fecal inflammatory markers are therefore best viewed as pieces of diagnostic information rather than stand-alone diagnoses.

Pancreatic Elastase and Digestive Function

The pancreas produces digestive enzymes needed to break down food.

When the pancreas does not produce enough digestive enzymes—a condition called exocrine pancreatic insufficiency—patients may experience symptoms such as:

• Chronic diarrhea

• Greasy or oily stools

• Difficulty maintaining weight

• Bloating

• Nutrient deficiencies

• Malabsorption

Fecal elastase-1 is one of the most commonly used stool tests for evaluating suspected pancreatic exocrine insufficiency.

The National Institute of Diabetes and Digestive and Kidney Diseases identifies stool elastase testing as the most commonly used stool test for this purpose.

A low result may suggest impaired pancreatic enzyme production, but the value still needs to be interpreted alongside symptoms and other findings.

Very watery stool can also affect some fecal elastase measurements, which is one example of why specimen quality and clinical context matter.

What Is the Gut Microbiome?

The human gastrointestinal tract contains an enormous community of microorganisms.

These include:

• Bacteria

• Viruses

• Fungi

• Archaea

• Other microorganisms

Collectively, these organisms and their genetic material are commonly referred to as the gut microbiome.

The microbiome participates in several biological processes, including digestion, metabolism, immune-system interactions, and the production of certain microbial compounds.

It is also highly dynamic.

Diet, medications, antibiotics, illness, environment, age, lifestyle, and many other factors can influence which microorganisms are detectable at a particular time.

The National Human Genome Research Institute describes the microbiome as a community of microorganisms that can change in response to diet, medications, exercise, and environmental exposures.

That variability is important when interpreting microbiome tests.

How Does Microbiome Testing Work?

Commercial gastrointestinal panels may analyze stool using several different laboratory technologies.

Depending on the test, these may include:

• Culture

• Quantitative PCR

• 16S ribosomal RNA sequencing

• Shotgun metagenomic sequencing

• Other molecular techniques

These approaches do not necessarily produce identical results.

One laboratory may report certain bacterial species, while another may group microorganisms differently or use a different reference population.

The laboratory may then compare a patient's sample with proprietary reference data and report concepts such as:

• Microbial diversity

• Relative abundance

• Commensal organisms

• Opportunistic organisms

• Potential pathogens

• Microbial balance

• Dysbiosis patterns

This information can be scientifically interesting.

The challenge is determining what it means clinically for an individual patient.

Can a Microbiome Test Diagnose Dysbiosis?

This is where careful interpretation becomes especially important.

"Dysbiosis" generally refers to an alteration in the composition or function of a microbial community.

Researchers have identified microbiome differences associated with numerous health conditions.

However, association does not necessarily establish causation.

A patient with a gastrointestinal condition may have a microbiome that differs from that of healthy controls, but this does not automatically tell us:

• Whether the microbiome change caused the disease

• Whether it resulted from the disease

• Which organism should be changed

• What an ideal microbiome should look like for that individual

• Whether changing the reported pattern would improve health

An international multidisciplinary consensus on microbiome testing published in 2025 concluded that evidence remains insufficient to recommend routine microbiome testing broadly in clinical practice.

That does not mean microbiome research is unimportant.

Quite the opposite: the microbiome is one of the most active areas of biomedical research.

It means the ability to measure microorganisms has advanced more rapidly than our ability to translate every measurement into a validated diagnosis or treatment recommendation.

Are All Bacteria Found on a Stool Test Harmful?

No.

Finding a microorganism does not automatically mean that it is causing disease.

The gastrointestinal tract normally contains a vast number of microorganisms, and many participate in normal biological functions.

The clinical significance of detecting an organism depends on several factors, including:

• Which organism was detected

• The method used to detect it

• Whether it is a recognized pathogen

• The patient's symptoms

• The patient's immune status

• Recent antibiotic use

• Travel or exposure history

• Stool pattern

• Other laboratory findings

• Whether inflammatory markers are elevated

One of the greatest risks of overinterpreting comprehensive stool testing is assuming that every organism identified outside a laboratory's preferred range requires eradication.

It does not.

Treatment should be directed toward a meaningful clinical problem rather than toward making every line on a laboratory report appear optimal.

Can Microbiome Testing Determine Which Probiotic You Need?

Not reliably in most clinical situations.

It is tempting to assume that if a stool report shows a lower amount of one bacterial group, simply taking that organism as a probiotic will correct the problem.

Human microbial ecosystems are much more complicated.

Microorganisms interact with:

• Other microorganisms

• Diet

• Intestinal transit time

• Bile acids

• Medications

• Immune function

• Gastrointestinal anatomy

• Host genetics

• Environmental exposures

Furthermore, many probiotics do not permanently colonize the intestine.

Some probiotics have evidence supporting particular clinical uses, but those recommendations generally come from clinical studies involving specific probiotic strains—not from matching a supplement to an individual's microbiome report.

Microbiome testing should therefore not automatically lead to large or complicated probiotic regimens.

What About Digestive and Metabolic Markers on Comprehensive Stool Panels?

Some specialty gastrointestinal panels include biomarkers intended to provide additional information about digestive physiology or microbial activity.

Depending on the laboratory, these may include measurements related to:

• Digestion

• Fermentation

• Microbial metabolism

• Short-chain fatty acids

• Intestinal immune activity

• Gut-barrier-related processes

• Other digestive biomarkers

The strength of evidence supporting these markers varies considerably.

Some findings may provide potentially useful contextual information.

Others have uncertain reference standards, limited validation, or unclear evidence showing that changing the marker improves patient outcomes.

This distinction is important.

A laboratory's ability to measure something accurately does not necessarily mean medicine knows exactly what should be done with the result.

Can Stool Testing Diagnose "Leaky Gut"?

Patients frequently encounter terms such as "intestinal permeability" or "leaky gut" when researching gastrointestinal testing.

Intestinal barrier function is a legitimate area of scientific research, and changes in intestinal permeability have been studied in several diseases.

However, "leaky gut syndrome" is not a single standardized diagnosis that can be definitively established by one commercially available stool marker.

Some specialty panels include markers intended to provide information about intestinal barrier-related processes.

Those results should be interpreted cautiously and should not be used alone to diagnose a broad collection of unrelated symptoms.

Symptoms still require an appropriate medical evaluation.

When Might Specialty Gastrointestinal Testing Be Helpful?

Specialty stool testing may be reasonable when there is a specific clinical question that the test is capable of addressing.

Examples may include selected patients with:

Persistent Diarrhea

Stool testing may help evaluate infection or intestinal inflammation depending on the duration of symptoms, exposures, travel history, medications, and other clinical features.

Suspected Intestinal Inflammation

Fecal calprotectin or lactoferrin may help determine whether additional evaluation for inflammatory gastrointestinal disease should be considered.

Possible Pancreatic Digestive Insufficiency

Fecal elastase may be useful when symptoms or medical history raise concern about inadequate pancreatic enzyme production.

Possible Gastrointestinal Infection

Targeted antigen, PCR, culture, or parasite testing may be appropriate when symptoms and exposure history support that possibility.

Persistent or Complex Gastrointestinal Symptoms

In selected cases, a broader panel may provide additional information after more common causes have been considered.

However, the test should still be ordered because it is expected to answer a specific question—not simply because symptoms are unexplained.

If you are unfamiliar with how advanced testing fits into the larger diagnostic process, our guide What Is Specialty Laboratory Testing? explains the role and limitations of these panels in greater detail.

When May Specialty Stool Testing Be Less Helpful?

Testing may provide limited value when there is no clear question being investigated.

Examples include ordering a large gastrointestinal panel solely because someone:

• Wants to "optimize" an otherwise asymptomatic microbiome

• Wants every detectable microorganism categorized

• Assumes an abnormal microbiome score identifies the cause of fatigue or brain fog

• Plans to treat every organism outside a reference range

• Wants to choose supplements solely from a microbiome profile

• Has symptoms that require a different diagnostic evaluation first

More testing creates more data.

More data does not necessarily create more useful information.

This is one reason we emphasize physician-guided specialty laboratory testing rather than automatically ordering the largest available panel.

What Specialty Stool Testing Cannot Tell You

A comprehensive gastrointestinal test generally cannot, by itself:

• Diagnose every digestive disorder

• Identify the single cause of nonspecific symptoms

• Prove that a particular microorganism is responsible for symptoms

• Determine the perfect microbiome composition for an individual

• Diagnose inflammatory bowel disease without appropriate clinical evaluation

• Rule out gastrointestinal cancer

• Replace colonoscopy when colonoscopy is medically indicated

• Replace imaging

• Replace evaluation for celiac disease

• Reliably determine every food a patient should or should not eat

• Determine that every detected organism requires treatment

• Guarantee that correcting an abnormal biomarker will improve symptoms

These limitations are not reasons to dismiss specialty testing.

They are reasons to use it appropriately.

Stool Represents Only Part of the Gastrointestinal Tract

Another limitation of microbiome testing is anatomical.

A stool specimen primarily reflects microorganisms and biological material that ultimately reach the stool.

It does not provide a complete representation of every microbial community throughout the gastrointestinal tract.

The stomach, small intestine, colon, mucosal surface, and stool can contain different microbial populations.

This is one reason stool microbiome testing should not be interpreted as a complete map of everything occurring throughout the digestive system.

Why Preparation and Collection Matter

The quality of a laboratory result begins before the specimen reaches the laboratory.

Patients should carefully follow the instructions included with their collection kit.

Depending on the test, clinicians may also need to know about:

• Recent antibiotics

• Probiotics

• Antimicrobial herbs

• Laxatives

• Digestive enzymes

• Acid-suppressing medications

• Anti-inflammatory medications

• Recent gastrointestinal illness

• Colonoscopy preparation

• Significant dietary changes

• Recent travel

These factors may influence what is detected or how the results should be interpreted.

Do not discontinue prescription medication solely to prepare for a specialty stool test unless the prescribing clinician or ordering physician specifically instructs you to do so.

How Physicians Interpret a Comprehensive Stool Panel

The laboratory report is only the beginning.

A physician may interpret gastrointestinal testing through several steps.

1. Start With the Clinical Question

Why was the test ordered?

A marker has much greater value when it addresses a defined clinical concern.

2. Review Symptoms and Medical History

Digestive symptoms are interpreted alongside:

• Duration

• Severity

• Stool characteristics

• Weight changes

• Diet

• Travel

• Medications

• Antibiotic exposure

• Family history

• Previous gastrointestinal disease

3. Separate Established Markers From Exploratory Markers

A physician should recognize that not every marker on a 20-page report carries the same clinical weight.

A substantially abnormal inflammatory marker may deserve more attention than a proprietary microbiome diversity score.

4. Compare With Conventional Testing

Specialty results may need to be interpreted with:

• Complete blood count

• Comprehensive metabolic panel

• Iron studies

• Celiac testing

• Thyroid testing

• Inflammatory markers

• Nutritional markers

• Imaging

• Endoscopy or colonoscopy

• Other condition-specific studies

Specialty testing should complement conventional evaluation when appropriate rather than compete with it.

5. Ask Whether the Finding Changes Management

One of the most useful questions in laboratory medicine is:

What would we do differently because of this result?

If the answer is "nothing," the value of obtaining the test may be limited.

6. Avoid Treating the Report Instead of the Patient

Not every abnormal result requires treatment.

The goal is not to normalize every number.

The goal is to identify findings that may meaningfully improve diagnosis, treatment, monitoring, or clinical decision-making.

Could a Stool Test Lead to Additional Testing?

Yes.

Specialty gastrointestinal testing sometimes raises questions rather than providing a final answer.

Depending on the findings and symptoms, reasonable next steps might include:

• Repeat or confirmatory laboratory testing

• Blood testing

• Celiac evaluation

• Imaging

• Gastroenterology referral

• Colonoscopy

• Upper endoscopy

• Pancreatic evaluation

• Targeted infection testing

• Nutritional evaluation

A specialty panel should not delay these evaluations when they are medically indicated.

Symptoms That Deserve Medical Evaluation

Digestive symptoms should not automatically be attributed to the microbiome.

Medical evaluation is particularly important for symptoms or findings such as:

• Visible blood in the stool

• Black or tarry stool

• Persistent or severe abdominal pain

• Persistent vomiting

• Unexplained weight loss

• Significant dehydration

• Persistent fever

• Anemia

• Progressive difficulty swallowing

• Persistent nighttime diarrhea

• Significant changes in bowel habits

• Strong family history of gastrointestinal cancer or inflammatory bowel disease

Depending on the severity of the symptoms, urgent or emergency evaluation may be appropriate.

Should Everyone Have a Comprehensive Stool or Microbiome Test?

No.

There is currently insufficient evidence to support broad routine microbiome testing for every healthy person. An international expert consensus specifically concluded that microbiome testing is not yet supported for widespread routine clinical use.

This is an evolving area of medicine.

Future research may identify specific microbial signatures that reliably predict disease, treatment response, medication effects, or nutritional interventions.

But clinical practice should distinguish between what is scientifically promising and what is already sufficiently validated to guide patient care today.

The Most Useful Question Is Not "How Comprehensive Is the Test?"

Comprehensive testing can sound reassuring.

A panel containing hundreds of organisms and dozens of biomarkers may appear more advanced than a test measuring one or two markers.

But clinical usefulness does not work that way.

A single well-validated measurement that answers the right clinical question may be more valuable than hundreds of findings with uncertain significance.

Before ordering gastrointestinal specialty testing, patients and physicians should ask:

• What are we trying to determine?

• Is this test validated for that purpose?

• What could cause an abnormal result?

• Would another established test answer the question better?

• Would the result change treatment or follow-up?

• What are the limitations?

• What will the testing cost?

Those questions help transform laboratory testing from data collection into medical decision-making.

Specialty Gastrointestinal Testing at Ask Dr. Hu

At Ask Dr. Hu, specialty laboratory testing is selected according to the clinical question rather than automatically ordering the same comprehensive panel for every patient.

Evaluation may begin with a review of:

• Current gastrointestinal symptoms

• Medical history

• Medication and supplement use

• Previous blood work

• Previous stool testing

• Diet

• Travel and exposure history

• Antibiotic use

• Previous imaging or gastrointestinal procedures

• Personal health goals

When specialty testing is appropriate, results are reviewed in the context of the complete clinical picture.

The objective is not simply to identify as many abnormalities as possible.

It is to determine which findings appear meaningful, which require confirmation, which may reasonably influence treatment, and which should be interpreted cautiously.

Arizona patients interested in testing can learn more about our Specialty Laboratory Testing services, read our complete specialty laboratory testing guide, or browse additional physician-written information in the Ask Dr. Hu Health Resources.

Frequently Asked Questions

Can a stool test diagnose IBS?

There is no single stool test that diagnoses irritable bowel syndrome.

Testing may sometimes be used to evaluate other conditions that can produce similar symptoms, such as gastrointestinal infection or intestinal inflammation. A diagnosis of IBS is based on the clinical picture and appropriate evaluation rather than a comprehensive microbiome panel alone.

Can microbiome testing tell me which foods I should eat?

Current microbiome testing may provide information about organisms present in a stool sample, but it generally cannot determine a definitive individualized list of foods that a person should or should not eat.

Nutrition recommendations should consider the patient's overall diet, symptoms, nutritional needs, medical conditions, preferences, and response to foods.

Does an abnormal microbiome result mean I have an infection?

No.

Many organisms normally live within the gastrointestinal tract.

The significance of a detected microorganism depends on its identity, quantity or relative abundance, test methodology, symptoms, immune status, and whether the organism is known to cause disease.

Should every potentially harmful bacterium on a stool test be treated?

No.

Detection alone does not necessarily establish disease or indicate that antimicrobial therapy is appropriate.

Unnecessary treatment can create side effects, medication interactions, antimicrobial resistance, and additional disruption of the gastrointestinal microbiome.

Can specialty stool testing replace a colonoscopy?

No.

Stool testing and colonoscopy answer different clinical questions.

When colonoscopy is recommended because of symptoms, screening indications, abnormal findings, or gastrointestinal risk, a comprehensive stool panel should not be considered a substitute.

Is gut microbiome testing useless?

No—but its current limitations need to be understood.

Microbiome analysis is an important research field and may eventually have broader applications in personalized medicine. At present, however, many microbiome measurements are better viewed as emerging information rather than definitive diagnostic findings.

Clinically established stool markers should be distinguished from exploratory microbiome measures when interpreting a comprehensive report.

Final Thoughts

Specialty gastrointestinal testing can provide valuable information, but the usefulness of each marker varies considerably.

Tests such as fecal calprotectin, selected pathogen testing, and fecal pancreatic elastase have established roles for specific clinical questions. Broader microbiome profiling may reveal interesting patterns, but our ability to convert every microbial finding into a reliable diagnosis or treatment recommendation remains limited.

The purpose of testing should therefore not be to collect as much information as possible.

It should be to answer the right question.

A thoughtful physician-guided approach combines symptoms, history, conventional evaluation, validated stool markers, and carefully selected specialty testing while recognizing where the science remains uncertain.

That approach helps patients receive the potential benefits of advanced gastrointestinal testing without turning every laboratory abnormality into a diagnosis.

Medical Accuracy and Editorial Standards

This article was written and clinically reviewed by YiQiu Hu, NMD, an Arizona-licensed naturopathic physician whose work includes individualized laboratory evaluation and interpretation.

The medical discussion on this page is informed by established gastroenterology guidance and current scientific literature, including resources from the American Gastroenterological Association, American College of Gastroenterology, National Institute of Diabetes and Digestive and Kidney Diseases, and the National Human Genome Research Institute.

Microbiome science is developing rapidly. A major international consensus statement on microbiome testing concluded that current evidence remains insufficient to recommend routine microbiome testing broadly in clinical practice. Testing should therefore be selected and interpreted according to the individual clinical situation rather than used as a universal screening tool.

Published: August 2026
Medically reviewed: August 2026

About the Author

Dr. YiQiu Hu, NMD is an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu. His clinical approach combines comprehensive medical evaluation, evidence-informed naturopathic care, thoughtful laboratory testing, preventive healthcare, and individualized treatment planning.

Through Ask Dr. Hu, patients throughout Arizona can receive physician-guided care through concierge medicine and individual specialty services, including advanced laboratory evaluation when clinically appropriate.

Learn more about Ask Dr. Hu's Specialty Laboratory Testing services or explore additional physician-written health resources.

Medical disclaimer: This article is provided for general educational purposes only. It does not provide individualized medical advice, establish a physician-patient relationship, or replace evaluation by a qualified healthcare professional. Laboratory testing and treatment recommendations should be individualized according to symptoms, medical history, examination findings, and other clinically relevant information.